{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:50:11Z","timestamp":1782964211973,"version":"3.54.5"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,15]]},"DOI":"10.18632\/oncotarget.11204","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T19:52:08Z","timestamp":1470945128000},"page":"74820-74833","source":"Crossref","is-referenced-by-count":43,"title":["Akt isoform specific effects in ovarian cancer progression"],"prefix":"10.18632","volume":"7","author":[{"given":"Nicolle M.","family":"Linnerth-Petrik","sequence":"first","affiliation":[{"name":"Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Santry","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Moorehead","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"J\u00fccker","sequence":"additional","affiliation":[{"name":"Center of Experimental Medicine, Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Wootton","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Petrik","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","article-title":"Latest research and treatment of advanced-stage epithelial ovarian cancer","volume":"10","author":"Herzog","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0025-6196(11)61196-8","article-title":"Current management strategies for ovarian cancer","volume":"82","author":"Hartmann","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"4","doi-asserted-by":"publisher","first-page":"25520","DOI":"10.18632\/oncotarget.4550","article-title":"The PI3K\/AKT\/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines","volume":"6","author":"Shen","year":"2015","journal-title":"Oncotarget"},{"key":"5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2006.02.018","article-title":"Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer","volume":"246","author":"Denkert","year":"2007","journal-title":"Cancer Lett"},{"key":"6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1042\/bj3310299","article-title":"Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha","volume":"331","author":"Alessi","year":"1998","journal-title":"Biochem J"},{"key":"7","doi-asserted-by":"crossref","first-page":"32124","DOI":"10.1074\/jbc.M302847200","article-title":"Protein kinase B alpha\/Akt1 regulates placental development and fetal growth","volume":"278","author":"Hemmings","year":"2003","journal-title":"J Biol Chem"},{"key":"8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB beta","volume":"112","author":"Coleman","year":"2003","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","article-title":"Role for Akt3\/protein kinase Bgamma in attainment of normal brain size","volume":"25","author":"Birnbaum","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/MCB.25.23.10407-10418.2005","article-title":"Dosage-dependent effects of Akt1\/protein kinase Balpha (PKBalpha) and Akt3\/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice","volume":"25","author":"Hemmings","year":"2005","journal-title":"Mol Cell Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1242\/dev.01864","article-title":"Essential role of protein kinase B gamma (PKB gamma\/Akt3) in postnatal brain development but not in glucose homeostasis","volume":"132","author":"Hemmings","year":"2005","journal-title":"Development"},{"key":"12","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/MCB.00722-06","article-title":"Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies","volume":"26","author":"Hemmings","year":"2006","journal-title":"Mol Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"e94595","DOI":"10.1371\/journal.pone.0094595","article-title":"Opposing functions of Akt isoforms in lung tumor initiation and progression","volume":"9","author":"Wootton","year":"2014","journal-title":"PLoS One"},{"key":"14","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s13277-013-1465-9","article-title":"The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines","volume":"35","author":"Stenerlow","year":"2014","journal-title":"Tumour Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1091\/mbc.e12-03-0213","article-title":"Distinct roles of AKT isoforms in regulating beta1-integrin activity, migration, and invasion in prostate cancer","volume":"23","author":"Ivaska","year":"2012","journal-title":"Mol Biol Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/0008-5472.CAN-06-3782","article-title":"Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2\/neu and MMTV-polyoma middle T transgenic mice","volume":"67","author":"Tsichlis","year":"2007","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-13-375","article-title":"Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice","volume":"13","author":"Moorehead","year":"2013","journal-title":"BMC Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2159-8290.CD-11-0170","article-title":"Genomic complexity and AKT dependence in serous ovarian cancer","volume":"2","author":"Taylor","year":"2012","journal-title":"Cancer Discov"},{"key":"19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2007.10.035","article-title":"Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer","volume":"108","author":"Petrik","year":"2008","journal-title":"Gynecol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9440(10)61714-2","article-title":"AKT1\/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells","volume":"159","author":"Cheng","year":"2001","journal-title":"Am J Pathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.cellsig.2011.07.003","article-title":"Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells","volume":"23","author":"Jucker","year":"2011","journal-title":"Cell Signal"},{"key":"22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4161\/cam.5.3.15790","article-title":"Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin","volume":"5","author":"Toker","year":"2011","journal-title":"Cell Adh Migr"},{"key":"23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/4419","article-title":"Emerging therapeutics for targeting Akt in cancer","volume":"21","author":"Basu","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"24","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.cellsig.2006.05.019","article-title":"Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway","volume":"18","author":"Jiang","year":"2006","journal-title":"Cell Signal"},{"key":"25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer","volume":"137","author":"Sasano","year":"2015","journal-title":"Gynecol Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1128\/MCB.00201-06","article-title":"Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding","volume":"26","author":"Lamb","year":"2006","journal-title":"Mol Cell Biol"},{"key":"27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1091\/mbc.e06-07-0593","article-title":"Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase\/Akt regulation of Glut1 activity and trafficking","volume":"18","author":"Rathmell","year":"2007","journal-title":"Mol Biol Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2010.12.329","article-title":"The impact of diabetes on survival in women with ovarian cancer","volume":"121","author":"Griggs","year":"2011","journal-title":"Gynecol Oncol"},{"key":"29","article-title":"Resveratrol inhibits ovarian tumor growth in an in vivo mouse model","author":"Liu","year":"2015","journal-title":"Cancer"},{"key":"30","first-page":"789174","article-title":"Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms","volume":"2012","author":"Brunetti","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ccr.2005.11.006","article-title":"A knotty turnabout?: Akt1 as a metastasis suppressor","volume":"8","author":"Yu","year":"2005","journal-title":"Cancer Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molcel.2005.10.033","article-title":"Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT","volume":"20","author":"Toker","year":"2005","journal-title":"Mol Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1158\/0008-5472.CAN-06-1968","article-title":"A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition","volume":"66","author":"Pearson","year":"2006","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"e0146370","DOI":"10.1371\/journal.pone.0146370","article-title":"Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4","volume":"11","author":"Jucker","year":"2016","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"Kotani","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00210-014-1032-y","article-title":"The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells","volume":"388","author":"Hsu","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biochi.2014.04.008","article-title":"CCT128930 induces cell cycle arrest, DNA damage, and autophagy independent of Akt inhibition","volume":"103","author":"Sun","year":"2014","journal-title":"Biochimie"},{"key":"38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1158\/1535-7163.MCT-05-0005","article-title":"Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo","volume":"4","author":"Klinghofer","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s13577-015-0112-8","article-title":"Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo","volume":"28","author":"Fujisawa","year":"2015","journal-title":"Hum Cell"},{"key":"40","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.18632\/oncotarget.6489","article-title":"Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis","volume":"7","author":"Moorehead","year":"2016","journal-title":"Oncotarget"},{"key":"41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2015.06.006","article-title":"Human platelet lysate improves human cord blood derived ECFC survival and vasculogenesis in three dimensional (3D) collagen matrices","volume":"101","author":"Yoder","year":"2015","journal-title":"Microvasc Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI24726","article-title":"Akt1\/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis","volume":"115","author":"Sessa","year":"2005","journal-title":"J Clin Invest"},{"key":"43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cmet.2007.10.007","article-title":"Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease","volume":"6","author":"Sessa","year":"2007","journal-title":"Cell Metab"},{"key":"44","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.109.196394","article-title":"Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis","volume":"29","author":"Sessa","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2012.04.006","article-title":"Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer","volume":"126","author":"Li","year":"2012","journal-title":"Gynecol Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0959-8049(11)70123-X","article-title":"Mutation and protein expression biomarkers correlate with response to AKT inhibition in a Phase I trial of the oral pan AKT inhibitor GSK2141795 (GSK795) in Patients (pts) with platinum resistant ovarian cancer","volume":"47","author":"Gabra","year":"2011","journal-title":"European Journal of Cancer"},{"key":"47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10555-012-9394-4","article-title":"The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies","volume":"31","author":"Muschel","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnci\/djq044","article-title":"Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth","volume":"102","author":"Pienta","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ygyno.2005.08.044","article-title":"A small molecule compound inhibits AKT pathway in ovarian cancer cell lines","volume":"100","author":"Lin","year":"2006","journal-title":"Gynecol Oncol"},{"key":"50","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1525-1438.2007.01177.x","article-title":"cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation","volume":"18","author":"Moorehead","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1096\/fj.14-261636","article-title":"Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer","volume":"29","author":"Petrik","year":"2015","journal-title":"FASEB J"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:11:38Z","timestamp":1589292698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":51,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2016,11,15]]}},"alternative-id":["11204","27533079"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11204","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]}}}